TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-β-catenin signaling
- PMID: 33264103
- PMCID: PMC7803540
- DOI: 10.18632/aging.104163
TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-β-catenin signaling
Abstract
The Wnt/β-catenin pathway plays vital roles in diverse biological processes, including cell differentiation, proliferation, migration, and insulin sensitivity. A recent study reported that the DNA-binding transcriptional factor SIX3 is essential during embryonic development in vertebrates and capable of downregulating target genes of the Wnt/β-catenin pathway in lung cancer, indicating negative regulation of Wnt/β-catenin activation. However, regulation of the SIX3-Wnt/β-catenin pathway axis remains unknown. We measured the expression of TRIM27 and SIX3 as well as investigated whether there was a correlation between them in lung cancer tissue samples. Herein, we found that the E3 ubiquitin ligase, TRIM27, ubiquitinates, and degrades SIX3. TRIM27 induces non-small cell lung cancer (NSCLC) cell proliferation and metastasis, and the expression of β-catenin, S100P, TGFB3, and MMP-9 were significantly inhibited by SIX3. Furthermore, XAV939 is a selective β-catenin-mediated transcription inhibitor that inhibited TRIM27- and SIX3-mediated NSCLC cell proliferation, migration, and invasion. Clinically, lung tissue samples of cancer patients showed increased TRIM27 expression and decreased SIX3 expression. Taken together, these data demonstrate that TRIM27 acts as an oncogene regulating cell proliferation and metastasis in NSCLC through SIX3-β-catenin signaling.
Keywords: SIX3; TRIM27; lung cancer; ubiquitination; β-catenin.
Conflict of interest statement
Figures






Similar articles
-
Wnt/β-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer.J Transl Med. 2024 Jun 13;22(1):565. doi: 10.1186/s12967-024-05380-8. J Transl Med. 2024. PMID: 38872189 Free PMC article. Review.
-
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.PLoS One. 2013 Aug 16;8(8):e71816. doi: 10.1371/journal.pone.0071816. eCollection 2013. PLoS One. 2013. PMID: 23977152 Free PMC article.
-
MicroRNA-625 inhibits the progression of non‑small cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/β-catenin pathway.Int J Mol Med. 2019 Jul;44(1):346-356. doi: 10.3892/ijmm.2019.4203. Epub 2019 May 20. Int J Mol Med. 2019. Retraction in: Int J Mol Med. 2022 Jun;49(6):78. doi: 10.3892/ijmm.2022.5134. PMID: 31115501 Retracted.
-
SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.J Transl Med. 2019 May 6;17(1):143. doi: 10.1186/s12967-019-1895-2. J Transl Med. 2019. PMID: 31060551 Free PMC article.
-
SIX3 function in cancer: progression and comprehensive analysis.Cancer Gene Ther. 2022 Nov;29(11):1542-1549. doi: 10.1038/s41417-022-00488-9. Epub 2022 Jun 28. Cancer Gene Ther. 2022. PMID: 35764712 Review.
Cited by
-
Multiple roles of S100P in pan carcinoma: Biological functions and mechanisms (Review).Oncol Rep. 2025 Jun;53(6):62. doi: 10.3892/or.2025.8895. Epub 2025 Apr 11. Oncol Rep. 2025. PMID: 40211698 Free PMC article. Review.
-
Integrated analysis of single-cell and bulk RNA-sequencing to predict prognosis and therapeutic response for colorectal cancer.Sci Rep. 2025 Mar 7;15(1):7986. doi: 10.1038/s41598-025-91761-y. Sci Rep. 2025. PMID: 40055390 Free PMC article.
-
Wnt/β-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer.J Transl Med. 2024 Jun 13;22(1):565. doi: 10.1186/s12967-024-05380-8. J Transl Med. 2024. PMID: 38872189 Free PMC article. Review.
-
TRIM27 promotes the Warburg effect and glioblastoma progression via inhibiting the LKB1/AMPK/mTOR axis.Am J Cancer Res. 2024 Jul 15;14(7):3468-3482. doi: 10.62347/TKFV8564. eCollection 2024. Am J Cancer Res. 2024. PMID: 39113875 Free PMC article.
-
Establishment of a SUMO pathway related gene signature for predicting prognosis, chemotherapy response and investigating the role of EGR2 in bladder cancer.J Cancer. 2024 May 20;15(12):3841-3856. doi: 10.7150/jca.96481. eCollection 2024. J Cancer. 2024. PMID: 38911380 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous